ArticleCell death & disease2023

CD317 maintains proteostasis and cell survival in response to proteasome inhibitors by targeting calnexin for RACK1-mediated autophagic degradation.

Jian Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.